InMode EBITDA 2018-2025 | INMD
InMode ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
InMode Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $113 |
| 2023 | $196 |
| 2022 | $199 |
| 2021 | $168 |
| 2020 | $73 |
| 2019 | $60 |
| 2018 | $24 |
| 2017 | $9 |
|
InMode Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $21 |
| 2025-06-30 | $23 |
| 2025-03-31 | $16 |
| 2024-12-31 | $28 |
| 2024-09-30 | $48 |
| 2024-06-30 | $18 |
| 2024-03-31 | $18 |
| 2023-12-31 | $51 |
| 2023-09-30 | $47 |
| 2023-06-30 | $57 |
| 2023-03-31 | $41 |
| 2022-12-31 | $60 |
| 2022-09-30 | $54 |
| 2022-06-30 | $49 |
| 2022-03-31 | $35 |
| 2021-12-31 | $54 |
| 2021-09-30 | $45 |
| 2021-06-30 | $42 |
| 2021-03-31 | $27 |
| 2020-12-31 | $36 |
| 2020-09-30 | $23 |
| 2020-06-30 | $8 |
| 2020-03-31 | $6 |
| 2019-12-31 | $18 |
| 2019-09-30 | $16 |
| 2019-06-30 | $16 |
| 2019-03-31 | $10 |
| 2018-12-31 | $1 |
| 2018-09-30 | $8 |
| 2018-06-30 | $8 |
| 2018-03-31 | $6 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.913B | $0.395B |
| InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.272B | 25.04 |
| EssilorLuxottica (ESLOY) | France | $167.297B | 0.00 |
| Boston Scientific (BSX) | United States | $146.836B | 33.58 |
| Stryker (SYK) | United States | $135.305B | 26.86 |
| Medtronic (MDT) | Ireland | $115.519B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.274B | 0.00 |
| Agilent Technologies (A) | United States | $41.813B | 27.06 |
| ResMed (RMD) | United States | $36.434B | 25.22 |
| GE HealthCare Technologies (GEHC) | United States | $33.786B | 16.16 |
| Koninklijke Philips (PHG) | Netherlands | $27.193B | 17.76 |
| Terumo (TRUMY) | Japan | $23.733B | 28.12 |
| Insulet (PODD) | United States | $22.765B | 70.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.541B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.850B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.243B | 7.46 |
| Bio-Rad Laboratories (BIO) | United States | $8.296B | 29.73 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.651B | 10.85 |
| Haemonetics (HAE) | United States | $3.233B | 13.98 |
| Envista Holdings (NVST) | United States | $3.203B | 18.38 |
| ICU Medical (ICUI) | United States | $3.201B | 20.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.020B | 13.46 |
| Perrigo (PRGO) | Ireland | $2.055B | 5.15 |
| LeMaitre Vascular (LMAT) | United States | $1.938B | 39.09 |
| Phibro Animal Health (PAHC) | United States | $1.745B | 17.42 |
| Curaleaf Holdings (CURLF) | Canada | $1.634B | 0.00 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.444B | 9.28 |
| Tilray Brands (TLRY) | Canada | $1.359B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.350B | 59.18 |
| Kestra Medical Technologies (KMTS) | United States | $1.343B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.84 |
| Neogen (NEOG) | United States | $1.299B | 24.92 |
| BioLife Solutions (BLFS) | United States | $1.294B | 386.00 |
| Valneva SE (VALN) | France | $0.765B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.738B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.493B | 16.99 |
| Evolus (EOLS) | United States | $0.465B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.378B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.356B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.261B | 0.00 |
| High Tide (HITI) | Canada | $0.253B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 145.33 |
| Owens & Minor (OMI) | United States | $0.241B | 2.42 |
| Viemed Healthcare (VMD) | United States | $0.238B | 18.97 |
| Exagen (XGN) | United States | $0.235B | 0.00 |
| Quanterix (QTRX) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.35 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.68 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Biote (BTMD) | United States | $0.140B | 5.68 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.107B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.01 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.21 |
| Nephros (NEPH) | United States | $0.055B | 40.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.26 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |